Chronic illness with complexity: Implication for performance measurement of optimal glycemic control

被引:86
作者
Meduru, Pramod
Helmer, Drew
Rajan, Mongala
Tseng, Chin-Lin
Pogoch, Leonard
Sambamoorthi, Usha
机构
[1] VA New Jersey Healthcare Syst, Ctr Healthcare Knowledge Management, E Orange, NJ 07018 USA
[2] VA New Jersey Healthcare Syst, War Related Illness & Injuiry Study Ctr, E Orange, NJ 07018 USA
[3] Univ Med & Dent New Jersey, Sch Med, Newark, NJ 07103 USA
[4] Morehouse Sch Med, Dept Community Hlth & Prevent Med, Atlanta, GA 30310 USA
[5] Rutgers State Univ, Inst Hlth Hlthcare Policy & Aging Res, New Brunswick, NJ 08903 USA
关键词
diabetes; veterans; performance measurement; glycemic control; chronic illness with complexity;
D O I
10.1007/s11606-007-0310-5
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
OBJECTIVE: To evaluate the association between chronic illness with complexity (CIC) and optimal glycemic control. PARTICIPANTS: Cross-sectional and longitudinal analyses of Diabetes Epidemiologic Cohort database of Veterans Health Administration (VHA) users with diabetes, less than 75 years old, with HbA1c tests in fiscal year (FY) 1999 and 2000, alive at FY2000 end (N=95,423). DESIGNIMEASUREMENTS: Outcomes were HbA1c<7% in each FY. CIC included three domains: nondiabetes physical illness, diabetes-related, and mental illness/substance abuse conditions. Other independent variables included age, gender, race, marital status, VHA priority status, and diabetes severity. Longitudinal analyses were restricted to patients with HbA1c >= 7% in FY1999 and included hospitalizations between final HbA1c's in FY1999 and FY2000. Multiple logistic regressions examined associations between CIC categories and HbA1c. RESULTS: In FY 1999, 33% had HbA1c <7%. In multivariate analyses, patients with nondiabetes physical illness and mental illness/substance abuse were more likely to have HbAlc <7% in FY1999 [adjusted odds ratios for cancer (AOR), 1.31; 95% CI (1.25-1.37); mental illness only, 1.18; 95% CI (1.14-1.22)]. Those with diabetes-related complications were less likely to have HbAlc <7% in FY1999. Associations generally held in FY2000. However, conditions in the mental illness/substance abuse complexity domain were less strongly associated with HbAlc <7%. Macrovascularrelated hospitalizations were positively associated with HbAlc <7% [AOR, 1.41; 95% CI (1.34-1.49)]. CONCLUSIONS: The association between CIC and HbAlc <7% is heterogeneous and depends on the domain of complexity. The varying associations of CIC categories with optimal glycemic control suggest the need for appropriate risk adjustment when using HbAlc <7% as a valid performance measure for diabetes quality of care.
引用
收藏
页码:408 / 418
页数:11
相关论文
共 31 条
  • [11] Kerr Eve A, 2002, Jt Comm J Qual Improv, V28, P555
  • [12] Who has diabetes? Best estimates of diabetes prevalence in the department of veterans affairs based on computerized patient data
    Miller, DR
    Safford, MM
    Pogach, LM
    [J]. DIABETES CARE, 2004, 27 : B10 - B21
  • [13] *NAT COMM QUAL ASS, 2006, HEDIS 2007, V2
  • [14] The impact of comorbid chronic conditions on diabetes care
    Piette, JD
    Kerr, EA
    [J]. DIABETES CARE, 2006, 29 (03) : 725 - 731
  • [15] Measuring progress toward achieving hemoglobin A1c goals in diabetes care -: Pass/fail or partial credit
    Pogach, Leonard
    Engelgau, Michael
    Aron, David
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (05): : 520 - 523
  • [16] Pogach LM, 2007, AM J MANAG CARE, V13, P133
  • [17] Quality of care of medicare beneficiaries with acute myocardial infarction: Who is included in quality improvement measurement?
    Rathore, SS
    Wang, YF
    Radford, MJ
    Ordin, DL
    Krumholz, HM
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2003, 51 (04) : 466 - 475
  • [18] The hazards of stroke case selection using administrative data
    Reker, DM
    Rosen, AK
    Hoenig, H
    Berlowitz, DR
    Laughlin, J
    Anderson, L
    Marshall, CR
    Rittman, M
    [J]. MEDICAL CARE, 2002, 40 (02) : 96 - 104
  • [19] Reduced hypoglycemia risk with insulin glargine - A metaanalysis comparing insulin glargine with human NPH insulin in type 2 diabetes
    Rosenstock, J
    Dailey, G
    Massi-Benedetti, M
    Fritsche, A
    Lin, ZN
    Salzman, A
    [J]. DIABETES CARE, 2005, 28 (04) : 950 - 955
  • [20] Developing a prediction rule from automated clinical databases to identify high-risk patients in a large population with diabetes
    Selby, JV
    Karter, AJ
    Ackerson, LM
    Ferrara, A
    Liu, J
    [J]. DIABETES CARE, 2001, 24 (09) : 1547 - 1555